SARS-CoV-2 (Covid-19) nucleocapsid (N) (Omicron, B.1.1.529) Recombinant Protein
SARS-CoV-2 (Covid-19) nucleocapsid (N) (Omicron, B.1.1.529) Recombinant Protein
Product Specifications
Source
E. coli
Field of Research
Infectious Disease & Virology
Concentration
Batch dependent
Purity
> 95% pure by SDS-PAGE. Ligand affinity purified.
Form
Liquid
Molecular Weight
This recombinant protein contains full length of Covid-19 Omicron nucleocapsid protein (carrying mutations of P13L, Δ31-33, R203K, G204R) with a MW of 46.2 kDa.
Storage Conditions
Upon receipt, quick spin before open vial, aliquot and store at ≤ –20°C. Avoid multiple freeze/thaw cycles
Notes
For research use only.
Applications Notes
Suitable for use in ELISA, CLIA, Lateral Flow, Western Blot, and other immune tests
Tested Applications
CLIA, ELISA, LF, WB
Preservative
PBS, pH 7.3 containing 0.1% ProClin300.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680050-500 1x 500 µL
IgA Secretory Component (SC05), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680009-500 1x 500 µL
MART-1 / Melan-A (M2-7C10), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940158-500 1x 500 µL
Cytokeratin 17 (E3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400819-100 1x 100 µL
Caldesmon, HMW (h-Caldesmon) (h-CALD), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472540-100 1x 100 µL
SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details